IN8bio Stock Quote INAB - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.25

Bid

0.231

Ask

0.2849

Volume

1,329,795

0.2303 Day's Range 0.2552

0.217 52 Week Range 1.93

Market Cap

18.121M

Previous Close

0.2404

Open

0.231

Last Trade

500

0.25

(formt)

Last Trade Time

Financial Volume

$ 329,424

VWAP

0.247726

Average Volume (3m)

1,259,479

Shares Outstanding

72,483,253

Dividend Yield

PE Ratio

-0.58

Earnings Per Share (EPS)

-0.41

Revenue

Net Profit

-30.01M

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.in8bio.com

Headquarters

Wilmington, Delaware, USA

Founded

IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $0.24. Over the last year, IN8bio shares have traded in a share price range of $ 0.217 to $ 1.93.

IN8bio currently has 72,483,253 shares outstanding. The market capitalization of IN8bio is $17.42 million. IN8bio has a price to earnings ratio (PE ratio) of -0.58.

Form 8-K - Current report

IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting

INB-100 continues to demonstrate durable complete remissions (CR) with no relapses observed in any acute myeloid leukemia (AML) patients including those with high-risk disease after a median...

IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that...

Form 8-K - Current report

IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting

50% of patients who received repeated doses (n=10) remained alive and in remission beyond the expected median overall survival (OS) from standard-of-care Stupp regimen while none of the patients...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0422	-14.4421629021	0.2922	0.3164	0.24	413108	0.26835529	CS
4	-0.07	-21.875	0.32	0.41	0.24	689200	0.32446998	CS
12	-0.035	-12.2807017544	0.285	0.5566	0.217	1259479	0.37858986	CS
26	-0.74	-74.7474747475	0.99	0.999	0.217	721365	0.41209241	CS
52	-1.25	-83.3333333333	1.5	1.93	0.217	544701	0.67137332	CS
156	-5.66	-95.7698815567	5.91	6.79	0.217	685641	2.0582461	CS
260	-9.75	-97.5	10	10.319	0.217	611656	2.1137244	CS

INAB - Frequently Asked Questions (FAQ)

What is the current IN8bio share price?

The current share price of IN8bio is $ 0.25

How many IN8bio shares are in issue?

IN8bio has 72,483,253 shares in issue

What is the market cap of IN8bio?

The market capitalisation of IN8bio is USD 17.42M

What is the 1 year trading range for IN8bio share price?

IN8bio has traded in the range of $ 0.217 to $ 1.93 during the past year

What is the PE ratio of IN8bio?

The price to earnings ratio of IN8bio is -0.58

What is the reporting currency for IN8bio?

IN8bio reports financial results in USD

What is the latest annual profit for IN8bio?

The latest annual profit of IN8bio is USD -30.01M

What is the registered address of IN8bio?

The registered address for IN8bio is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the IN8bio website address?

The website address for IN8bio is www.in8bio.com

Which industry sector does IN8bio operate in?

IN8bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	281.23M

Symbol

Price

Vol.